CervoMed Inc (CRVO)

2.33 +0.10 (+4.48%) USD  |  NASDAQ  |  Jan 03, 16:00
2.34 +0.01 (+0.43%) After-Hours: 20:00
More

CervoMed Enterprise Value: -27.43M for Jan. 3, 2025

Enterprise Value Chart

View Enterprise Value for CRVO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Inovio Pharmaceuticals Inc -14.05M
Abbott Laboratories 204.86B
Leap Therapeutics Inc 65.54M
AIM ImmunoTech Inc 10.41M
Protalix BioTherapeutics Inc 128.69M

Enterprise Value Related Metrics

Net Income (Quarterly) -4.754M
Total Expenses (Quarterly) 5.396M
EPS Diluted (Quarterly) -0.55
Earnings Yield -70.66%